应对专利挑战,强生146亿美元收购中枢神经公司

阿尔法工场
16 Jan

(原标题:应对专利挑战,强生146亿美元收购中枢神经公司)导语:2024年医疗行业并购低迷后重拾活力。强生(Johnson & Johnson)近日宣布,已同意以约146亿美元收购专注于中枢神经系统疾病治疗的公司Intra-Cellular Therapeutics(细胞内生物技术公司)。根据公告,强生将以每股132美元的价格收购该公司,这一价格较周五收盘价溢价39%。此前,彭博社曾报道该交易正在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10